Understanding how nicotine use affects diabetes and finding new treatments.
Preventative Biomarkers and Potential Pharmacotherapies for Nicotine Use and Diabetes
This study is looking at how nicotine use might be connected to diabetes, especially how issues with metabolism can affect a person's dependence on nicotine, and it aims to find better ways to help people with diabetes who want to quit smoking.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas El Paso NIH-funded |
| Lab location | 1 site (El Paso, United States) |
| Project ID | NIH-10890119 on NIH RePORTER |
What this research studies
This research investigates the relationship between nicotine use and diabetes, focusing on how metabolic disorders influence nicotine dependence. Using rodent models, the team will explore how insulin resistance and other metabolic factors affect nicotine behavior and the potential for pharmacological interventions. The study aims to identify biomarkers associated with nicotine dependence and evaluate the effectiveness of medications that target insulin resistance in reducing nicotine use. By examining these factors, the research seeks to provide insights that could lead to better treatment strategies for individuals with diabetes who use nicotine.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with diabetes who also use nicotine or are at risk of nicotine dependence.
Not a fit: Patients who do not have diabetes or do not use nicotine may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for nicotine dependence in patients with diabetes, potentially reducing health risks associated with both conditions.
How similar studies have performed: While the specific approach of this research is novel, previous studies have shown that understanding metabolic factors can influence addiction behaviors.
Where this research is happening
El Paso, United States
- University of Texas El Paso — El Paso, United States (Active)
Researchers
- Principal investigator: Odell, Laura Elena — University of Texas El Paso
- Study coordinator: Odell, Laura Elena
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.